High level of AKT activity is associated with resistance to MEK inhibitor AZD6244 (ARRY-142886)

MEK/ERK activities are increased in many primary lung cancers, and MEK inhibitors have been tested clinically for treatment of non-small cell lung cancers. The molecular mechanisms of resistance to MEK inhibitors have not been clearly demonstrated, however, and no molecular biomarker that can predic...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Meng, Jieru, Peng, Henry, Dai, Bingbing, Guo, Wei, Wang, Li, Ji, Lin, Minna, John D., Chresta, Christine M., Smith, Paul D., Fang, Bingliang, Roth, Jack A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2009
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2835993/
https://ncbi.nlm.nih.gov/pubmed/19783898
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky